Clinical Trials Browser

Phase 1/2 × OTHER × Glioblastoma × Clear all

NCT06814496 2026-05-20

RABBIT

Phase 1/2 Recruiting

CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

NCT07392957 2026-05-14

Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma

Phase 1/2 Not yet recruiting

Glioblastoma

NCT02331498 2026-05-06

PAZOGLIO

Phase 1/2 Active not recruiting

Glioblastoma

NCT04922723 2026-04-28

PRIDE

Phase 1/2 Active not recruiting

Glioblastoma

NCT02866747 2026-04-14

STERIMGLI

Phase 1/2 Completed

Glioblastoma

NCT06607692 2026-04-14

LUPARPED

Phase 1/2 Recruiting

CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT04528680 2026-04-13

SC9/ABX

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Phase 1/2 Not yet recruiting

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

NCT03277638 2026-04-09

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

Phase 1/2 Active not recruiting

Brain Neoplasms, Glioblastoma

NCT03596086 2026-03-30

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

Phase 1/2 Recruiting

Astrocytoma, Glioblastoma

NCT03603405 2026-03-30

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Phase 1/2 Recruiting

Astrocytoma, Glioblastoma

NCT04801147 2026-03-27

DENDR1

Phase 1/2 Completed

Glioblastoma

NCT06672575 2026-02-27

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

Phase 1/2 Recruiting

Glioblastoma

NCT06622434 2026-02-20

NAVIG-1

Phase 1/2 Recruiting

Glioblastoma

NCT07410494 2026-02-18

SELECT-CAR-NK

Phase 1/2 Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Liver Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute

NCT07410676 2026-02-18

EBNK-ST-001

Phase 1/2 Recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Bronchogenic, Disease, Esophageal Neoplasms, Glioblastoma, Kidney Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT03529448 2026-02-12

GEINOCANN

Phase 1/2 Completed

Glioblastoma

NCT07389278 2026-02-05

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

Phase 1/2 Not yet recruiting

Glioblastoma, Glioma

NCT07391215 2026-02-05

5G-PEARL

Phase 1/2 Recruiting

Glioblastoma

NCT05084430 2026-01-22

Study of Pembrolizumab and M032 (NSC 733972)

Phase 1/2 Recruiting

Astrocytoma, Glioblastoma, Recurrence, Gliosarcoma

NCT06630260 2026-01-21

5G-RUBY

Phase 1/2 Recruiting

Glioblastoma

NCT04677049 2026-01-02

Study of Niacin in Glioblastoma

Phase 1/2 Suspended

Glioblastoma

NCT05039281 2025-12-19

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

Phase 1/2 Recruiting

Glioblastoma, Gliosarcoma

NCT07145047 2025-12-19

Clinical Study of Oncolytic Virus in Glioblastoma

Phase 1/2 Recruiting

Glioblastoma

NCT05956821 2025-12-08

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Phase 1/2 Recruiting

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Glioblastoma, Oligodendroglioma

NCT03233152 2025-11-21

GlitIpNi

Phase 1/2 Active not recruiting

Glioblastoma, Recurrence

NCT06059690 2025-10-08

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Phase 1/2 Recruiting

Glioblastoma

NCT05734560 2025-10-06

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Phase 1/2 Recruiting

Glioblastoma

NCT03174197 2025-09-24

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Phase 1/2 Completed

Glioblastoma, Gliosarcoma

NCT07180927 2025-09-18

DLL3 CAR-T Therapy Targeting Brain Tumors

Phase 1/2 Recruiting

Glioblastoma

NCT06102525 2025-09-05

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Phase 1/2 Recruiting

Glioblastoma

NCT04977375 2025-09-03

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

NCT07120620 2025-08-13

PriCoTTF

Phase 1/2 Completed

Glioblastoma

NCT03672721 2025-08-11

IA Carboplatin + Radiotherapy in Relapsing GBM

Phase 1/2 Recruiting

Glioblastoma, Recurrence

NCT04019262 2025-06-18

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

Phase 1/2 Active not recruiting

Glioblastoma, Lymphopenia

NCT03673787 2025-05-14

IceCAP

Phase 1/2 Active not recruiting

Glioblastoma

NCT03665545 2025-05-13

IMA950-106

Phase 1/2 Completed

Glioblastoma

NCT02715609 2025-04-10

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Phase 1/2 Completed

35 enrolled 16 charts

Glioblastoma

NCT01269853 2025-04-09

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

Phase 1/2 Recruiting

Astrocytoma, Glioblastoma, Neoplasms

NCT01386710 2025-04-09

Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma

Phase 1/2 Suspended

Astrocytoma, Glioblastoma, Neoplasms

NCT02861898 2025-04-09

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma

NCT03213002 2025-04-09

CAPTEM

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Neoplasms

NCT06690216 2025-03-30

PD-L1-PET

Phase 1/2 Enrolling by invitation

CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma

NCT04590664 2025-02-25

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Phase 1/2 Recruiting

Glioblastoma

NCT04881032 2025-02-13

NANO-GBM

Phase 1/2 Active not recruiting

Glioblastoma

NCT03914742 2025-01-14

BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations

Phase 1/2 Completed

67 enrolled 18 charts

Glioblastoma

NCT05590689 2024-12-16

ALA-RDTinGBM

Phase 1/2 Recruiting

Glioblastoma

NCT01291420 2024-12-09

Dendritic Cell Vaccination for Patients with Solid Tumors

Phase 1/2 Completed

BreastCNSGastrointestinalGenitourinaryOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Renal Cell, Glioblastoma, Sarcoma, Colorectal Neoplasms

NCT06640582 2024-11-05

BAH2472

Phase 1/2 Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

NCT01985087 2024-10-31

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70

Phase 1/2 Active not recruiting

Glioblastoma